In this podcast, Spencer Group’s CEO, Julian Minett, talks with senior leaders Steve Powell, Chairman at Cisiv, and Andrew Rut, CEO at Metadvice, about artificial intelligence and the pharmaceutical industry.
They talk about the future of PharmaTech adoption, including whether AI will impact drug discovery, development, and approval. They also discuss AI’s impact on both the back end of drug development, as well as in the hands of doctors and front-line staff.
To learn more about Civis, click here.
To learn more about Metadvice, click here.
Listen to the podcast below: